Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 58

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 58
---
 the principle of “one country, two systems”.

<div align='center'>30</div>

However, as the government of mainland China
may choose to exercise significant oversight and discretion, and the policies, regulations, rules, and the enforcement of laws of the
government of mainland China to which we are subject may change rapidly and with little or no advance notice to us or our shareholders.
As a result, the application, interpretation, and enforcement of new and existing laws and regulations in mainland China are often uncertain.
In addition, these laws and regulations may be interpreted and applied inconsistently by different agencies or authorities, and may be
inconsistent with our current policies and practices. New laws, regulations, and other government directives in mainland China may also
be costly to comply with, and such compliance or any associated inquiries or investigations or any other government actions may:

| ● | delay                      
 or impede our development; |

| ● | result in negative publicity     
 or increase our operating costs; |

| ● | require significant management 
 time and attention; and/or     |

| ● | subject us to remedies, administrative                                                                                                 
 penalties and even criminal liabilities that may harm our business, including fines assessed for our current or historical operations, 
 or demands or orders that we modify or even cease our business practices.                                                              |

We are aware that recently, the government of
mainland China initiated a series of regulatory actions and statements to regulate business operations in certain areas in mainland China
with little or no advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over
mainland China-based companies listed overseas using variable interest entity structure, adopting new measures to extend the scope of
cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. Since these statements and regulatory actions are new,
it is highly uncertain how soon legislative or administrative regulation making bodies will respond and what existing or new laws or
regulations or detailed implementations and interpretations will be modified or promulgated, if any, and the potential impact such modified
or new laws and regulations will have on our daily business operation, the ability to accept foreign investments and list on a U.S. or
other foreign exchange.

The PRC government may intervene or influence our operations at any time or may exert control over offerings conducted overseas and foreign investment in Hong Kong-based issuers, which may result in a material change in our operations and/or the value of the Class A Ordinary Shares. For example, there is currently no restriction or limitation under the laws of Hong Kong